<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Use of cell-free DNA for secondary screening for Down syndrome</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Use of cell-free DNA for secondary screening for Down syndrome</h1>
<div class="graphic"><div class="figure"><div class="ttl">Use of cell-free DNA for secondary screening for Down syndrome</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Pregnant women can choose to have a blood (serum-based) screening test to find out whether they have a high or low risk of having a baby with Down syndrome. The blood test has been offered for many years. Most women find they have a low risk and continue with routine care. In some women, the blood test will find a high risk. These women can find out for sure if the baby has Down syndrome by having an invasive test like amniocentesis. There is now a new option for the women at high risk (shaded box and dashed arrows): a new blood test that looks at the baby's cell-free DNA that is in the mother's blood and again determines if she is high or low risk. Most women find they have a low risk and continue with routine care. A few women will have a high risk (50 percent or more)Â on the DNA test, and the DNA test does not work (test failure 1 to 5 percent) for some others. These women would still need an invasive test to know for certain if the baby has Down syndrome.</div><div id="graphicVersion">Graphic 103160 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
